Meet the 2020 Laureates: Richard J. Santen, MD

santen

Richard J. Santen, MD

Fred Conrad Koch Lifetime Achievement Award

Richard J. Santen, MD, is professor of medicine at the University of Virginia and a former president of the Endocrine Society. His impressive clinical and research career has focused on both prostate and breast cancer. His pioneering work led to the development of first, second, and third generation aromatase inhibitors for the treatment of hormone-dependent breast cancer. His laboratory has continued with seminal publications on the study of the mechanisms relating estrogens to breast cancer and the biology and natural history of endocrine-dependent forms of breast cancer.

He has published over 400 manuscripts and chapters, predominantly related to the role that estrogen plays in breast cancer development. His expertise in estrogens led to a strong clinical interest in the treatment of menopause and to his selection by the Endocrine Society to write a definitive Scientific Statement on this topic. He enlisted 34 internationally diverse, expert clinicians to write this treatise.

For his work in the development of aromatase inhibitors, now standard of care for hormone dependent breast cancer, he received the Susan Komen Foundation Brinker International Award for breast cancer clinical research in 1993. Other awards include the American Association of Clinical Chemistry Distinguished Science Award, the Robert H. Williams Distinguished Leadership Award of the Endocrine Society, and the William L. McGuire Memorial Lectureship Award for breast cancer.

During his illustrious career, Dr. Santen has been a major contributor to the Endocrine Society, serving as chair of the Finance Committee, spearheading a financial plan to secure the long-term stability of the Endocrine Society, initiating the International Scholars program of the Endocrine Society, and, as president of the Endocrine Society, leading an initiative to support the next generation of endocrinologists. Recognized as a leading clinical endocrinologist, Santen’s achievements have spanned the clinical, research, teaching, and administrative spectrum.

You may also like

  • Webinar Will Examine Concerns Around Compounding Anti-Obesity Medications

    Endocrine Society to host virtual Science Writers Conference Nov. 14 Surging demand for a new generation of highly effective anti-obesity medications is creating interest in compounded versions of these medications. Endocrine Society experts will discuss the importance of prescribing FDA-approved medications to treat obesity during the Society’s Virtual Science Writers Conference on November 14. What:…

  • Bianco Named Vice President and Vice Provost for Research, Chief Research Officer at UTMB

    Antonio Bianco, MD, PhD, has joined the University of Texas Medical Branch (UTMB) as vice president and vice provost, research, and chief research officer, effective Sept. 1. A renowned physician-scientist, scholar, and research leader, Bianco possesses an impressive academic career that includes influential contributions to the field of thyroid diseases and an enduring commitment to…

Find more in